AR078170A1 - Metodos para el tratamiento de tumores cerebrales - Google Patents
Metodos para el tratamiento de tumores cerebralesInfo
- Publication number
- AR078170A1 AR078170A1 ARP100103326A ARP100103326A AR078170A1 AR 078170 A1 AR078170 A1 AR 078170A1 AR P100103326 A ARP100103326 A AR P100103326A AR P100103326 A ARP100103326 A AR P100103326A AR 078170 A1 AR078170 A1 AR 078170A1
- Authority
- AR
- Argentina
- Prior art keywords
- meta
- sodium
- arsenite
- treatment
- brain tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Uso de meta arsenita de sodio, caracterizado porque es en la elaboracion de una composicion farmacéutica para el tratamiento de un tumor cerebral en un paciente humano, en donde dicha meta arsenita de sodio atraviesa la barrera hematoencefálica humana. Reivindicacion 8: Un conjunto de elementos, caracterizado porque comprende una o más unidades de dosificacion de meta arsenita de sodio formulada para una administracion oral o intravenosa y una o más unidades de dosificacion de un agente quimioterapéutico anti-tumor cerebral diferente de la meta arsenita de sodio y formulada para una administracion oral o intravenosa. Reivindicacion 9: El conjunto de elementos de la reivindicacion 8, caracterizado porque el agente quimioterapéutico anti-tumor cerebral se selecciona entre agentes alquilantes, antifolatos y topoisomerasas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24364809P | 2009-09-18 | 2009-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR078170A1 true AR078170A1 (es) | 2011-10-19 |
Family
ID=43756836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100103326A AR078170A1 (es) | 2009-09-18 | 2010-09-10 | Metodos para el tratamiento de tumores cerebrales |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110070314A1 (es) |
| EP (1) | EP2477635A4 (es) |
| JP (1) | JP2013505242A (es) |
| KR (1) | KR20120048706A (es) |
| CN (1) | CN102753188A (es) |
| AR (1) | AR078170A1 (es) |
| AU (1) | AU2010295841A1 (es) |
| BR (1) | BR112012008310A2 (es) |
| CA (1) | CA2772777A1 (es) |
| IN (1) | IN2012DN02195A (es) |
| MX (1) | MX2012002922A (es) |
| RU (1) | RU2012108439A (es) |
| SG (1) | SG179192A1 (es) |
| TW (1) | TW201114431A (es) |
| WO (1) | WO2011034775A2 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107412771A (zh) * | 2009-09-10 | 2017-12-01 | 柯密纳克斯公司 | 靶向癌症干细胞的耐药性癌症疗法 |
| KR101309036B1 (ko) * | 2011-05-30 | 2013-09-16 | 주식회사 코미팜 | 방사선 민감도 증진용 약학 조성물 |
| US8781202B2 (en) * | 2012-07-26 | 2014-07-15 | International Business Machines Corporation | Tumor classification based on an analysis of a related ultrasonic attenuation map |
| US10076652B2 (en) * | 2015-08-10 | 2018-09-18 | Chang Gung University | Method for ultrasound-mediated delivery system to monitor molecular penetration |
| AU2019239671B2 (en) | 2018-03-22 | 2025-02-27 | Komipharm International Australia Pty Ltd | Pharmaceutical composition comprising meta arsenite and method of manufacture |
| KR20220020633A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 주사제 조성물 |
| KR20220020635A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 외용제 조성물 |
| KR20220020637A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2358624T3 (es) * | 1997-10-15 | 2011-05-12 | Polarx Biopharmaceuticals, Inc. | Composiciones y métodos para el tratamiento de enfermedades neoplásicas primarias y metastásicas usando compuestos de arsénico. |
| KR20020083678A (ko) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물 |
| EP2042182B1 (en) * | 2002-04-10 | 2013-05-22 | Komipharm International Co., Ltd. | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| WO2006104292A1 (en) * | 2005-03-31 | 2006-10-05 | Komipharm International Co., Ltd. | Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts |
| EP1721615A1 (en) * | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
-
2010
- 2010-09-09 BR BR112012008310A patent/BR112012008310A2/pt not_active IP Right Cessation
- 2010-09-09 JP JP2012529803A patent/JP2013505242A/ja not_active Withdrawn
- 2010-09-09 WO PCT/US2010/048314 patent/WO2011034775A2/en not_active Ceased
- 2010-09-09 RU RU2012108439/15A patent/RU2012108439A/ru not_active Application Discontinuation
- 2010-09-09 IN IN2195DEN2012 patent/IN2012DN02195A/en unknown
- 2010-09-09 SG SG2012018859A patent/SG179192A1/en unknown
- 2010-09-09 AU AU2010295841A patent/AU2010295841A1/en not_active Abandoned
- 2010-09-09 CN CN2010800414064A patent/CN102753188A/zh active Pending
- 2010-09-09 EP EP10817682A patent/EP2477635A4/en not_active Withdrawn
- 2010-09-09 CA CA2772777A patent/CA2772777A1/en not_active Abandoned
- 2010-09-09 KR KR1020127008137A patent/KR20120048706A/ko not_active Ceased
- 2010-09-09 MX MX2012002922A patent/MX2012002922A/es not_active Application Discontinuation
- 2010-09-10 TW TW099130699A patent/TW201114431A/zh unknown
- 2010-09-10 AR ARP100103326A patent/AR078170A1/es unknown
- 2010-09-10 US US12/879,316 patent/US20110070314A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20110070314A1 (en) | 2011-03-24 |
| BR112012008310A2 (pt) | 2017-06-06 |
| JP2013505242A (ja) | 2013-02-14 |
| AU2010295841A1 (en) | 2012-03-29 |
| WO2011034775A3 (en) | 2011-10-06 |
| WO2011034775A2 (en) | 2011-03-24 |
| KR20120048706A (ko) | 2012-05-15 |
| MX2012002922A (es) | 2012-09-07 |
| TW201114431A (en) | 2011-05-01 |
| EP2477635A4 (en) | 2013-03-27 |
| EP2477635A2 (en) | 2012-07-25 |
| IN2012DN02195A (es) | 2015-08-21 |
| CA2772777A1 (en) | 2011-03-24 |
| SG179192A1 (en) | 2012-05-30 |
| RU2012108439A (ru) | 2013-10-27 |
| CN102753188A (zh) | 2012-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2757373C2 (ru) | Комбинированная терапия противоопухолевым алкалоидом | |
| AR078170A1 (es) | Metodos para el tratamiento de tumores cerebrales | |
| US20220071959A1 (en) | Combination therapies for the treatment of cancer | |
| ES2653615T3 (es) | Pluralidad de dosis de LAG-3 recombinante para su uso en la provocación de una respuesta inmunitaria de monocitos | |
| WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
| CY1119886T1 (el) | Μεθοδος βιομηχανικης κατασκευης μιας φαρμακευτικης συνθεσης στην μορφη δισκιων παρατεταμενης απελευθερωσης που περιεχουν πιρφενιδονη και χρηση αυτων στην υποστροφη χρονιας νεφρικης ανεπαρκειας, καψικης συσπασης μαστου και ηπατικης ινωσης σε ανθρωπους | |
| MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
| AR068185A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
| WO2008131057A3 (en) | Sustained release formulations of opioid and nonopioid analgesics | |
| EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| PH12014500386A1 (en) | Combination treatment for hepatitis c | |
| AR089862A1 (es) | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA | |
| ATE494889T1 (de) | Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol | |
| JP2006500346A5 (es) | ||
| BR112013010829A2 (pt) | composição farmacêutica intravenenosa para proporcionar alívio da dor e / ou da inflamação, uso e método da mesma | |
| MX395613B (es) | COMPOSICIONES DE ZINC-y-PGA Y MÉTODOS PARA TRATAR EL CANCER. | |
| RU2010151660A (ru) | Способы лечения множественной миеломы | |
| ATE353650T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| UA115250C2 (uk) | Фармацевтичні комбінації | |
| JP2005530735A5 (es) | ||
| AR079000A1 (es) | Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas | |
| EA200801670A1 (ru) | Комбинированная противораковая терапия с перфузией изолированного органа | |
| JP2016503063A5 (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |